Related Experiment Video
Updated: Sep 9, 2025

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Ambient Artificial Intelligence Scribes in Oncology: Adoption, Feasibility, Acceptability, and Appropriateness
Abigail E Baldwin-Medsker1, Susan Chimonas2, Suryan P Goyal1
1Digital Informatics and Technology Solutions, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
None:
Hospitals are looking to AI and other innovative applications to help alleviate provider burden and dissatisfaction associated with clinical documentation in oncology. Ambient artificial intelligence (AI) scribes are a promising technology to address these issues. However, they generally have not been optimized for oncology. This study aimed to evaluate an ambient AI scribe application with oncology providers to determine opportunities and potential challenges.This prospective pilot study of a scribe application was conducted over 4 months at a high-volume cancer center in New York City. Qualitative (interviews) and quantitative (surveys and utilization) data were collected to assess adoption, feasibility, acceptability, and appropriateness. The analysis included descriptive statistics and thematic content analysis.Thirty-one providers were included across oncology specialties. Twenty-five providers used the application at least once; of these, 18 completed a survey and 21 completed an interview. Providers used the application in 620 (13.9%) out of 4,449 in-person outpatient visits. Out of 18 survey respondents, 17 (94%) indicated they used the AI-drafted content at least sometimes, demonstrating feasibility. For acceptability, 11 (61%) indicated a moderate, strong, or very strong desire for continued access to the technology. All providers interviewed advocated for continued investment in ambient technology. Metrics around appropriateness showed variability based on its accuracy in capturing complex clinical scenarios and in the types of patients the technology was used with. For example, providers used the technology for 21.1% of new visits but only 12.2% of follow-up visits.This study demonstrated the potential for ambient AI scribes to be useful in oncology. Future research should evaluate the use of this technology at scale as it may realize workflow efficiencies and improve the clinical documentation process.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Current Trends in Nursing II
Non-equilibrium in the Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...

